1192 HIGH SUSTAINED VIROLOGICAL RESPONSE RATES WITH RESPONSE-GUIDED DANOPREVIR PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE, HCV GENOTYPE 1 PATIENTS: ATLAS STUDY FINAL RESULTS
2009 ◽
Vol 16
(12)
◽
pp. 853-859
◽
2009 ◽
Vol 16
(10)
◽
pp. 724-731
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):